Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.10
Delayed Data
As of 10:01am ET
 +0.55 / +2.68%
Today’s Change
13.60
Today|||52-Week Range
33.00
+12.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-5.1M-18.9M-8.2M-25.2M
 
 
 
 
 
Depreciation5.8M5.6M6.1M5.8M
 
 
 
 
 
Total Other Cash Flow10.9M21.5M23.2M47.8M
 
 
 
 
 
Funds From Operations10.9M3.6M24.1M46.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-21.9M29.0M13.9M-4.6M
 
 
 
 
 
Net Cash Flow - Operating Activities32.8M-25.4M10.3M51.4M
 
 
 
 
 
 
InvestingIncrease In Investments-1.0K0.000.000.00
 
 
Capital Expenditures-1.6M-5.8M-3.0M-1.6M
 
 
 
 
 
Fixed Asset Disposal--2.7M0.000.00
 
 
Net Assets From Acquisitions 1.7M----0.00
 
 
Net Cash Flow Investing-316.0K-3.1M-3.1M-1.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings-28.0K----0.00
 
 
Long Term Debt Reduction---2.2M-184.0K0.00
 
 
 
Net Proceeds Stock Sale847.0K5.5M0.001.5M
 
 
 
 
Common Preferred Redeemed0.000.00-60.0K0.00
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.000.000.00--
Other Uses - Financing15.0K0.000.000.00
 
 
Net Cash Flow - Financing804.0K3.2M-244.0K1.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.4M361.0K545.0K154.0K
 
 
 
 
 
 
Net Change In Cash33.3M-25.3M6.9M51.2M